Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
antisense therapeutics
|
| gptkbp:founded |
1989
|
| gptkbp:founder |
gptkb:Stanley_T._Crooke
|
| gptkbp:headquartersLocation |
gptkb:Carlsbad,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Isis Pharmaceuticals, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableCollaboration |
gptkb:Bayer
gptkb:Pfizer gptkb:Sanofi_Genzyme gptkb:Biogen gptkb:AstraZeneca gptkb:Janssen_Biotech gptkb:Novartis gptkb:Roche gptkb:Akcea_Therapeutics GlaxoSmithKline |
| gptkbp:notableEmployee |
gptkb:Sarah_Boyce
gptkb:Stanley_T._Crooke gptkb:C._Frank_Bennett Brett Monia Richard Geary |
| gptkbp:notableProduct |
gptkb:Spinraza
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:renamed |
gptkb:Ionis_Pharmaceuticals,_Inc.
2015 |
| gptkbp:stockSymbol |
gptkb:IONS
|
| gptkbp:website |
https://www.ionispharma.com/
|
| gptkbp:bfsParent |
gptkb:NASDAQ:_IONS
|
| gptkbp:bfsLayer |
7
|